
 |
| Who Is Recip?
A privately owned Swedish pharmaceutical company, Recip AB, is
quickly becoming an American household name. Recip manufactures and
distributes ThyroSafe™, the trade name for their potassium iodide
tablets, that prevents cancer of the thyroid caused by radiation
following a nuclear and other emergency.
In such an emergency, radioactive iodine is released into the air in
what is known as “fall-out” which may be breathed in or
swallowed. The thyroid gland needs iodine to control metabolism and
regulate growth. However, the thyroid gland cannot distinguish
between regular iodine and radioactive iodine. If radioactive iodine
has been released into the atmosphere by a nuclear emergency, it
will be absorbed by the thyroid gland. But the thyroid gland will
only take in a certain amount of iodine. If harmless iodine fills
the thyroid gland, like ThyroSafe™ potassium iodide, there is no
room for the radioactive iodine.
That is how Recip ThyroSafe™ protects you and more importantly,
your children from developing thyroid
cancer after a nuclear emergency.
Recip has been supplying European countries with potassium iodide
for many years. After the 9/11 disaster, an American division of
Recip was established in the United States to bring Recip ThyroSafe™
into America. Today, ThyroSafe™ is the only FDA approved potassium
iodide tablet that comes in the child appropriate 65 milligram
dosage.
ThyroSafe™ tablets are 65 milligrams each and are
easily recognized on the shelf by its light green/yellow box.
In case of a radiation emergency, and upon notification by
local health authorities, children aged three to eighteen
take one tablet daily. Children 1 month to 3 years of age take
one-half tablet. Neonates under 1 month should take one-quarter
tablet. The tablets are cross-scored for easy breaking. Adults over
eighteen years of age take two tablets daily. Local health authorities
will inform you how long to continue taking ThyroSafe™.
Recip products, which include pharmaceuticals, food supplements and
herbal medicines, are sold in Sweden through the state pharmacy.
Recip’s introduction to the United States, ThyroSafe™ potassium
iodide tablets, will be distributed by Recip US, and sold in food
and drug chains.
Recip is a member of Euralliance Farma, a European alliance of
independent pharmaceutical companies, which markets over-the-counter
medicines and para-pharmaceutical products. Potassium iodide is a
very important safeguard to European lives and it should provide
protection as well as some peace of mind to Americans who are at
risk of nuclear radiation should a nuclear emergency occur.
back to top |
 |





Potassium Iodide has been protecting Europe
for years |